Necrobiotic xanthogranuloma associated with monoclonal gammopathy: successful treatment with lenalidomide and dexamethasone

Ann Hematol. 2016 Mar;95(4):671-2. doi: 10.1007/s00277-016-2604-3. Epub 2016 Jan 27.

Authors

Bhagirathbhai R Dholaria¹, Mark Cappel², Vivek Roy³

Affiliations

¹ Department of Hematology-Oncology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL, 32224, USA. brd.850@gmail.com.
² Department of Dermatology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL, 32224, USA.
³ Department of Hematology-Oncology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL, 32224, USA.

PMID: 26814914
DOI: 10.1007/s00277-016-2604-3

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Angiogenesis Inhibitors / administration & dosage
Antineoplastic Agents, Hormonal / administration & dosage
Dexamethasone / administration & dosage*
Drug Therapy, Combination
Humans
Lenalidomide
Male
Middle Aged
Necrobiotic Xanthogranuloma / complications
Necrobiotic Xanthogranuloma / diagnosis
Necrobiotic Xanthogranuloma / drug therapy*
Paraproteinemias / complications
Paraproteinemias / diagnosis
Paraproteinemias / drug therapy*
Thalidomide / administration & dosage
Thalidomide / analogs & derivatives*
Treatment Outcome

Substances

Angiogenesis Inhibitors
Antineoplastic Agents, Hormonal
Thalidomide
Dexamethasone
Lenalidomide